345 related articles for article (PubMed ID: 1914458)
1. Effects of various IUDs on the composition of cervical mucus.
Jonsson B; Landgren BM; Eneroth P
Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
[TBL] [Abstract][Full Text] [Related]
2. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
4. IUD-induced changes in cervical secretion content of albumin, IgG and complement C3c.
Fleetwood L; Landgren BM; Eneroth P
Contraception; 1984 May; 29(5):465-70. PubMed ID: 6744862
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
Shi JP; Wu XR
J Tongji Med Univ; 1993; 13(2):126-8. PubMed ID: 8230357
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
[TBL] [Abstract][Full Text] [Related]
7. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
8. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
9. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
12. Endometrial morphological changes in IUD users: a review.
Sheppard BL
Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
[TBL] [Abstract][Full Text] [Related]
13. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
14. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
15. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
16. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
[TBL] [Abstract][Full Text] [Related]
17. Early chorionic activity in women bearing inert IUD, copper IUD and levonorgestrel-releasing IUD.
Videla-Rivero L; Etchepareborda JJ; Kesseru E
Contraception; 1987 Aug; 36(2):217-26. PubMed ID: 3123135
[TBL] [Abstract][Full Text] [Related]
18. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
19. The levonorgestrel-releasing intrauterine device.
Toivonen J
Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function after seven years' use of a levonorgestrel IUD.
Barbosa I; Olsson SE; Odlind V; Goncalves T; Coutinho E
Adv Contracept; 1995 Jun; 11(2):85-95. PubMed ID: 7491859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]